Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Shareholder Letter

 

re: "...Normally the PDS revenues (over 20 M in the last quarter)..."

 

wow-- that one sailed right past me in the past couple weeks-- was there confirmation on that? 

 

thanks in advance 

Share
New Message
Please login to post a reply